Sunshine Lake Pharma Co., Ltd.
Clinical trials sponsored by Sunshine Lake Pharma Co., Ltd., explained in plain language.
Sunshine Lake Pharma is a Chinese pharmaceutical company developing innovative drugs and generics.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Healthy men needed to test new Injection's safety Results expected Sep 2026 (estimated)
- New pill HEC585 aims to slow lung scarring in rare disease Results expected Dec 2026 (estimated)
- New pill targets RET-Driven cancers in early trial Results expected Dec 2026 (estimated)
- Liver health may change how cancer drug works Results expected Dec 2026 (estimated)
- Healthy volunteers needed to test safety of experimental NASH drug Results expected Dec 2026 (estimated)
-
Lung cancer drug trial pulled before it even started
Disease control CancelledThis study was designed to test the safety and effectiveness of ningetinib in people with advanced non-small cell lung cancer that has a specific genetic change called MET exon 14 skipping. The trial planned to enroll adults aged 18-75 with stage IIIB-IV cancer. However, the stud…
Phase 2 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New IPF pill enters mid-stage trial – could it slow lung decline?
Disease control OngoingThis study tests an experimental tablet called HEC585 in 270 adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing harder. Participants receive either HEC585, a placebo (dummy pill), or an active comparator (Pirfenidone) to see if HEC…
Phase 2 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC